Topical composition for improved healing of open wounds
AssigneeEleos Pharmaceuticals, Inc.
InventorsMona E. BUICE, David M. SAILORS, Joshua Z. GREESON
Life of this patent
Estimating the term…
Abstract
The present disclosure is concerned with compositions comprising insulin and a pharmaceutically acceptable topical carrier. The present disclosure is also concerned with methods of using these compositions for the treatment of a skin ailment such as a diabetic ulcer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Claims30
A method of treating a skin ailment in a human patient in need thereof, the method comprising:
- (a) determining that the patient has a glucose level at the site of the skin ailment or in surrounding tissue within about one inch of the outer edge of the skin ailment that is greater than the patient's systemic blood glucose level;
- and
- (b) administering to the patient a pharmaceutical composition comprising insulin and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is topically administered to the patient at the site of the skin ailment or on the surrounding tissue.
A method of treating a skin ailment in a human patient in need thereof that has been determined to have a glucose level at the site of the skin ailment or in surrounding tissue within about one inch of the outer edge of the skin ailment that is greater than the patient's systemic blood glucose level, the method comprising administering to the patient a pharmaceutical composition comprising insulin and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is topically administered to the patient at the site of the skin ailment or on the surrounding tissue.
Dependencies are inferred from the claim text.